Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-15-010020
Filing Date
2015-05-14
Accepted
2015-05-14 06:07:51
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q govx20150331_10q.htm 10-Q 386093
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 17413
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 17293
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 6115
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 5878
  Complete submission text file 0001437749-15-010020.txt   2431640

Data Files

Seq Description Document Type Size
6 EXHIBIT 101.INS govx-20150331.xml EX-101.INS 223814
7 EXHIBIT 101.SCH govx-20150331.xsd EX-101.SCH 28273
8 EXHIBIT 101.CAL govx-20150331_cal.xml EX-101.CAL 18329
9 EXHIBIT 101.DEF govx-20150331_def.xml EX-101.DEF 186341
10 EXHIBIT 101.LAB govx-20150331_lab.xml EX-101.LAB 136602
11 EXHIBIT 101.PRE govx-20150331_pre.xml EX-101.PRE 196766
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA 2Q 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA 2Q 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

EIN.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52091 | Film No.: 15860190
SIC: 8731 Services-Commercial Physical & Biological Research